908 Devices Inc (NASDAQ:MASS) — Market Cap & Net Worth
Market Cap & Net Worth: 908 Devices Inc (MASS)
908 Devices Inc (NASDAQ:MASS) has a market capitalization of $299.86 Million ($299.86 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14695 globally and #3472 in its home market, demonstrating a 12.66% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 908 Devices Inc's stock price $8.01 by its total outstanding shares 37813621 (37.81 Million). See 908 Devices Inc (MASS) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
908 Devices Inc Market Cap History: 2020 to 2026
908 Devices Inc's market capitalization history from 2020 to 2026. Data shows change from $2.15 Billion to $302.89 Million (-27.55% CAGR).
Index Memberships
908 Devices Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #404 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1445 of 3165 |
Weight: 908 Devices Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
908 Devices Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 908 Devices Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.53x
908 Devices Inc's market cap is 3.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.15 Billion | $26.89 Million | -$12.82 Million | 80.07x | N/A |
| 2021 | $978.24 Million | $42.21 Million | -$22.17 Million | 23.18x | N/A |
| 2022 | $288.14 Million | $46.85 Million | -$31.74 Million | 6.15x | N/A |
| 2023 | $424.27 Million | $50.23 Million | -$36.40 Million | 8.45x | N/A |
| 2024 | $83.19 Million | $59.63 Million | -$72.21 Million | 1.40x | N/A |
| 2025 | $198.52 Million | $56.20 Million | -$36.64 Million | 3.53x | N/A |
Competitor Companies of MASS by Market Capitalization
Companies near 908 Devices Inc in the global market cap rankings as of August 3, 2026.
Key companies related to 908 Devices Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
908 Devices Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, 908 Devices Inc's market cap moved from $2.15 Billion to $ 302.89 Million, with a yearly change of -27.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $302.89 Million | +52.57% |
| 2025 | $198.52 Million | +138.64% |
| 2024 | $83.19 Million | -80.39% |
| 2023 | $424.27 Million | +47.24% |
| 2022 | $288.14 Million | -70.55% |
| 2021 | $978.24 Million | -54.57% |
| 2020 | $2.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of 908 Devices Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $299.86 Million USD |
| MoneyControl | $299.86 Million USD |
| MarketWatch | $299.86 Million USD |
| marketcap.company | $299.86 Million USD |
| Reuters | $299.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more